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Conclusions. These data provide evidence that there is aNephrotoxin exposure in utero reduces glomerular number in
positive correlation between the susceptibility to glomerulo-sclerosis-prone but not sclerosis-resistant mice.
sclerosis in adulthood and a reduction in nephron number inBackground. We have previously found that nephron num-
utero. Thus, exposure to nephrotoxins in utero compounds theber was not fixed, that is, there was a direct correlation between
risk of renal failure as an adult in sclerosis-prone individuals.low birth weight and decreased nephron number in infants. In
sclerosis-prone rats, we found that gentamicin exposure in utero
induced a reduction in glomerular number and aggravated
glomerulosclerosis in adults. In mice, we found that an inborn
We have previously found that in studies of kidneys50% reduction in nephron number, caused by the Os muta-
from victims of sudden infant death syndrome, nephrontion, was associated with glomerulosclerosis in sclerosis-prone
(ROP1/1) mice, but not in sclerosis-resistant (C57BL/6J) number and birth weight were inversely correlated [1].
mice. Because the genetic background determined the response These data suggested that nephron number is not fixed
to decreased nephron number, we asked whether the suscepti- and could be modulated by in utero events. Because thebility changes in glomerular number and glomerulosclerosis
number of nephrons in humans does not increase afterwere linked.
birth, intrauterine renal events leading to a reduction inMethods. Gentamicin was administered before and after the
onset of fetal nephrogenesis. (1) Prior to the onset of nephro- glomerular number is an important clinical issue. Oligo-
genesis, two groups of pregnant mice were treated from embry- meganephronia, a disease with severe nephron deficit at
onic day (E) E8 to E12. In group A, early glomerular develop- birth, often leads to end-stage renal disease (ESRD) inment was studied by placing ureteric ridges removed on E12
infancy [2]. However, a recent study of 29 children within vitro for four days, following which the ureteric bud branches
oligomeganephronia followed between 3 and 17 yearsand glomeruli were counted using lectin staining. In group B,
nephron number was determined in spontaneously delivered showed that not all developed ESRD [3]. One reason
14-day-old (14PN) pups by counting glomeruli. (2) After the for this discrepancy could be that the development of
onset of nephrogenesis, to determine the direct effects of genta-
progressive glomerulosclerosis requires a permissive ge-micin on nephron induction, ureteric ridges were placed in
netic background in addition to a reduction in nephronorgan culture at E12 of normal gestation, in the presence or
absence of gentamicin. The number of glomeruli and ureteric number.
bud branches were counted after six days in culture. We previously showed that glomerulosclerosis devel-
Results. A decrease in glomerular number and ureteric bud oped only in sclerosis-prone mice, data in agreementbranches was observed in sclerosis-prone (ROP1/1) mice,
with that in children [4]. For these studies, we used miceirrespective of whether gentamicin was administered prior to
with an inborn 50% reduction in nephron number causedor after the onset of nephrogenesis. Glomerular number and
ureteric bud branching were not decreased by gentamicin in by a radiation-induced oligosyndactylism mutation (Os),
sclerosis-resistant (C57BL/6) mice. which has been back-crossed onto sclerosis-prone (ROP)
and sclerosis-resistant (C57) mice. When ROP Os/1 and
1 See Editorial by Avner, p. 1962. C57BL/6 Os/1 mice were subjected to unilateral ne-
2 Both authors contributed equally to this work. phrectomy in adulthood or were rendered diabetic, only
ROP Os/1 mice developed glomerulosclerosis [5, 6].Key words: gentamicin, C57BL/6, ROP1/1, glomerulosclerosis, toxin,
neonate. Thus, the sclerotic response depended on the genetic
background and was not stimulus specific.Received for publication December 10, 1998
We previously found that the glomerular number wasand in revised form April 5, 1999
Accepted for publication June 29, 1999 decreased in pups of female sclerosis-prone (Sprague-
Dawley) rats that had received gentamicin from embry- 1999 by the International Society of Nephrology
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Table 1. Data from mothers and pups (Protocol 1B)
BW BW gain
E8 E8–12
Gestation time Pups/litter BIW/litter
Group N g (h 1 18 days)c N g
C57BL/6
Saline 5 23.863.3 4.460.6 31.269.9 7.861.6 1.3760.15
Gentamicin 7 23.761.9 3.2 60.7a 31.469.9 7.061.8 1.3760.06
ROP1/1
Saline 5 24.962.2 3.361.1 24.165.3 6.561.9 1.1860.09
Gentamicin 6 24.562.3 0.5 61.0b 30.366.6 6.362.0 1.1560.07
Data are mean 6 sd. Abbreviations are: BW, body weight; BIW, birth weight.
a P , 0.01 vs. saline-treated C57BL/6
b P , 0.001 vs. saline-treated ROP1/1
c Hours after usual gestation time of 18 days
Table 2. Data from pups used for glomerular counting at post-natal day 14 (PN14; Protocol 1B)
BIW BW
KW GN GN/KW GN/BW KW/BW
Group N g mg N3103 N/mg N/g %
C57BL/6
Saline 20 1.3760.15 7.7 60.4 62.367.5 13.961.7 235622 17996224 0.84 60.05
Gentamicin 28 1.3760.11 7.5 61.1 61.564.2 14.161.5 232627 19426563 0.79 60.07
ROP1/1
Saline 16 1.2060.09 7.2 60.7 48.164.1 12.361.0 256622 17016132 0.67 60.07
Gentamicin 10 1.2160.08 7.860.6a 52.965.6a 11.161.6a 211649b 14306266b 0.6960.08
Data are mean 6 sd. Abbreviations are: BIW, BW, KW, birth, body and kidney weight; GN, glomerular number. BW, KW and GN were assessed at PN14.
a P , 0.05 vs. saline-exposed ROP1/1 pups
b P , 0.01 vs. saline-exposed ROP1/1 pups
onic day (E) E8 to E12 [7]. A direct effect of gentamicin ROP1/1 mice) and saline-treated females (two mice
per strain) was anesthetized with sodium pentobarbitalon nephron number was demonstrated using metaneph-
ros organ cultures [8]. In this study, gentamicin was cho- (60 mg/kg, intraperitoneally). The embryos were col-
lected and weighed. Kidneys were removed aseptically,sen as an example of a nephrotoxin that can reduce
glomerular number to determine whether the suscepti- freed of exogenous tissue, and used in an organ culture
system described previously for rats [8, 9]. Briefly, kid-bility to glomerulosclerosis and a reduction in nephron
number were linked. neys were placed in individual dishes on a 0.8 mm Milli-
pore AA filter (Millipore, Saint-Quentin-en-Yvelines,
France) floating on serum-free Dulbecco’s modified Ea-
METHODS
gle’s medium/Ham’s F12 (vol/vol) supplemented with 15
Experimental protocols mm HEPES, 45 mm NaHCO3 (pH 7.45 6 0.05), 6.8 3
1029 m selenium, 8.3 3 1027 m insulin, 2 3 1029 m triiodo-Maternal treatment prior to the onset of nephrogenesis.
(a) Effects on glomerular number and ureteric bud branch- thyronine, and 7 3 1028 m prostaglandin E1. Transferrin-
free medium was used to prevent further mesenchymal-ing. Female 10- to 12-week-old C57BL/6 mice (Charles
River, Paris, France) and ROP1/1 mice (Jackson Labo- epithelial conversion, allowing us to restrict the analysis
to those glomeruli induced at the time of explantationratories, Bar Harbor, ME, USA) were housed with males
of the same strain overnight. The next day was defined (E12) [10]. Kidneys were cultured for four days in a
humidified incubator with 5% CO2 at 378C. The mediumas E0.
Pregnant females (17 C57BL/6 and 15 ROP1/1 mice) contained no antibiotics or fungicides and was changed
daily. Glomerular number and ureteric bud branchesreceived 100 mg/kg gentamicin intramuscularly (genta-
micin sulfate in saline) or an equal volume of saline were assessed by lectin staining.
(b) Effects on the final number of glomeruli. The sec-from E8 to E12. This period overlaps the early stages
of nephrogenesis in mice. At this time, there are no ond group of gentamicin- and saline-treated females (12
C57BL/6 and 11 ROP1/1; Table 1) was allowed to de-morphologically recognizable glomeruli. Injections were
given into the thigh to avoid abdominal manipulation. liver spontaneously. Maternal weight and the duration
of gestation were recorded. Pups were weighed withinOn E12, one group of gentamicin- (3 C57BL/6 and 2
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Fig. 1. Diagram of experimental protocols.
The black arrows indicate the period of genta-
micin (G) treatment. (1) Pregnant females re-
ceived 100 mg/kg gentamicin or saline intra-
muscularly from embryonic day (E) E8 to E12.
(A) Pregnancy was interrupted on E12, and
embryonic kidneys were cultured for four days
without transferrin to block further mesenchy-
mal-epithelial conversion. (B) Kidneys were
processed for glomerular counting on PN14.
(2) Kidneys were removed from normal em-
bryos on E12 and grown six days in organ cul-
ture. One kidney was exposed to 10 mg/ml gen-
tamicin; the contralateral kidney was cultured
in normal medium as an internal control.
10 hours following birth and were individually marked. supports normal organogenesis and metanephros differ-
entiation [8–10]. One kidney was cultured in the presenceThe litter size was randomly reduced to eight pups. On
PN14, pups were weighed and killed with an overdose of 10 mg/ml gentamicin. The contralateral kidney was
cultured in normal medium and served as an internalof sodium pentobarbital. The left kidney was removed
and weighed, and preparation for glomerular counts control. The use of paired experiments has been found
to reduce interassay variability because the in vitrocommenced the same day (Table 2).
Treatment after the onset of nephrogenesis. Effects on growth of embryonic kidneys varies between embryos
of the same litter. The glomerular number was assessedglomerular number in culture. Untreated pregnant fe-
males (three C57BL/6 and four ROP1/1) were anesthe- following lectin staining. All reagents were purchased
from Sigma Chemical Company (St. Louis, MO, USA).tized at E12. Kidneys were removed and grown for six
days in a medium described earlier in this article with A summary of the experimental protocols is shown in
Figure 1.the addition of 6.2 3 1028 m transferrin. This medium
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Fig. 2. Lectin histochemistry. Following gentamicin (B and D) or saline (A and C) treatment of the mothers from gestation E8 to E12, embryonic
kidneys were placed in culture for four days (Protocol 1A). Glomerular and tubular segments were visualized by PNA and HPA coupled to the
same fluorochrome. Gentamicin treatment did not affect glomerular number or ureteric bud branching in C57BL/6 kidneys (B vs. A). By contrast,
a decrease in glomerular number and ureteric bud ends was observed in gentamicin-treated ROP1/1 kidneys (D vs. C). No glomeruli were found
in lateral areas (arrows; bar represents 300 mm).
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branches was performed by two observers. All of the
glomeruli or ureteric buds were visualized in each speci-
men by focusing through the specimen [8]. This was
accomplished by moving the stage so that all fields from
the bottom of the specimen to its most superficial parts
were examined. The results are means of the four counts.
Determination of glomerular number in postnatal
(PN14) kidneys
The kidney was decapsulated and macerated in 50%
HCl for 30 minutes at 378C. After rinsing with tap water,
the brei was stored overnight at 48C. The flask was gently
shaken on the following day. The tissue was homoge-
nized with a glass stirring rod, and the tubules and glo-
meruli were suspended in 25 ml of tap water. Glomeruli
were counted in two different 500 ml aliquots by each
of two investigators. The total number of glomeruli was
calculated using the mean of the four counts.
Statistical analysis
The Mann–Whitney test was used to evaluate differ-
ences between kidneys of embryos from treated and
untreated mothers (Protocol 1A). Treated and untreated
females of each strain and their offspring (Protocol 1B)
were compared by the unpaired Student’s t-test. Pairs
of kidneys in each strain treated in vitro (Protocol 2A)
were compared by Wilcoxon signed rank test. All data
were expressed as mean 6 sd. The significance level was
set at P , 0.05.
RESULTS
Fig. 3. Quantitation of glomeruli (A) and ureteric bud ends (B) in
Maternal gentamicin treatment prior to the onsetC57BL/6 and ROP1/1 kidneys after in utero exposure to gentamicin
(j) or saline (h; Protocol 1A). The number of glomeruli and ureteric of nephrogenesis
bud ends was not different in gentamicin-treated (N 5 12) and saline-
Effects on glomerular number and ureteric bud branch-treated (N 5 9) C57BL/6 kidneys. By contrast, significantly fewer glomer-
uli and ureteric bud ends were found in gentamicin- (N 5 7) than in ing. Transferrin-free medium prevents the further in-
saline-treated (N 5 8) ROP1/1 kidneys (P , 0.05, data are mean 6 sd). duction of glomeruli in vitro. Thus, any glomeruli identi-
fied had been induced at the time of explantation.
After in utero exposure to gentamicin or saline, the
kidneys did not have further drug exposure. Gentamicin-Assessment of glomerular number and ureteric bud
treated ROP1/1 kidneys had fewer glomeruli than theirbranching in culture
saline-treated controls (36% decrease, P , 0.05; Figs. 2
Glomerular and ureteric bud labeling were performed and 3A). The decrease in glomerular number was
as previously described [11]. Briefly, filter-grown kidneys restricted to the lateral areas of gentamicin-treated
were fixed in 2% paraformaldehyde, rinsed several times ROP1/1 kidneys (Fig. 2D). In contrast, the number of
in phosphate-buffered saline (PBS), and permeabilized glomeruli found in gentamicin-treated C57BL/6 kidneys
with saponin. They were then treated with vibrio cholera was identical to that in saline-treated controls.
neuraminidase and incubated with peanut agglutinin There was a 20% decrease in the number of ureteric
(PNA)-coupled rhodamine. For organ cultures grown in buds in gentamicin-treated ROP1/1 kidneys (P , 0.05;
the absence of transferrin, both PNA and Helix pomatia Figs. 2 and 3B). In contrast, gentamicin did not affect
agglutinin (HPA) coupled to the same fluorochrome the number of ureteric bud branches in C57BL/6 kidneys.
were used in order to visualize both glomerular and Gentamicin treatment did not affect the elongation of
tubular segments. Preparations were observed on an Op- existing ureteric buds in ROP1/1 or C57BL/6 kidneys.
tiphot microscope equipped with an episcopic fluores- Effects on the final number of glomeruli. Body weight
was similar in both strains at treatment onset (Table 1).cent attachment. Counting of glomeruli and ureteric bud
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Fig. 4. Lectin histochemistry. Kidneys from E12 normal embryos after six days in culture in the absence (A and C) or presence (B and D) of 10
mg/ml gentamicin (Protocol 2A). Glomeruli were stained with rhodamine-coupled PNA. A and B represent a pair of C57BL/6 kidneys, and C and
D a pair of ROP1/1 kidneys. The same number of glomeruli was found in gentamicin-treated C57BL/6 kidneys as in the saline-treated contralateral
kidneys (B vs. A). The gentamicin-treated ROP1/1 kidneys had a reduced number of glomeruli (D vs. C) compared with controls (bar represents
250 mm).
Gentamicin-injected ROP1/1 mice gained much less (16 hr) delivery. The resultant loss of pups among
ROP1/1 litters of gentamicin-treated mothers resultedweight from E8 to E12 than did saline-injected ROP1/1
mice (0.5 6 1.0 vs. 3.3 6 1.1 g, P , 0.001). In con- in a reduction in the number of pups available for glo-
merular counting.trast, gentamicin-injected C57BL/6 females gained only
slightly less weight than did saline-injected C57BL/6 fe- Four mice per litter were randomly selected for glo-
merular counting at PN14 (Table 2). Gentamicin-treatedmales during this same period of gestation (3.2 6 0.7 vs.
4.4 6 0.6 g, P , 0.01). ROP1/1 pups had a higher body weight (BW) and kid-
ney weight (KW) and lower glomerular numbers (GN;Gentamicin treatment did not influence gestation
time, number of pups/litter, or birth weight/litter in either 11.1 6 1.6 3 103 vs. 12.3 6 1.0 3 103, P , 0.05, 10%
decrease) at PN14 than saline-treated ROP1/1 pups.strain. The frequency distribution of birthweights did
not differ between treatment groups or mouse strains The GN/KW ratios (211 6 49 vs. 256 6 22 number/mg)
and GN/BW (1430 6 266 vs. 1701 6 132 number/g)(data not shown). Among saline-treated litters, one
ROP1/1 litter died (mean birthweight 1.05 g). No in- were also significantly decreased in the gentamicin-
treated ROP1/1 group compared with the saline-crease in perinatal mortality was observed in gentamicin-
treated C57BL/6 litters. However, three of six gentami- treated ROP1/1 group (P , 0.01). In contrast, there
were no differences between saline-treated and gentami-cin-treated ROP1/1 mothers cannibalized their litters.
The mean birthweight was low in two of the cannibalized cin-treated C57BL/6 pups with respect to birthweight,
BW, KW, GN, GN/KW, and GN/BW and KW/BW ratioslitters (,1.10 g). The death of the third gentamicin-
treated litter appeared to be related to a prolonged at PN14.
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examining nephron development in vitro. A post-treat-
ment reduction of glomerular number was found in
ROP1/1 mice irrespective of whether or not gentamicin
was administered prior to or after the onset of nephro-
genesis.
Nephrogenesis begins at approximately E12 and is not
complete until a few days after birth in mice [12]. The
initial stage of nephron formation was targeted in this
study by starting gentamicin administration at E8. Be-
cause we previously found that low birthweight was asso-
ciated with nephron reduction, gentamicin administra-
tion was limited to five days to avoid intrauterine growth
retardation [13].
The reduction of glomerular number and ureteric bud
branches observed in vitro in ROP1/1 kidneys was re-
stricted to the polar areas (Fig. 2D). Nephrons are first
induced and attached to buds in the midpolar area,
whereas in polar areas, nephron induction occurs later
[14]. Our findings suggest that gentamicin altered ure-
teric bud branching rather than nephron induction in
ROP1/1 mice. This is consistent with our previous find-
ings in rats [11]. The reduction of glomerular number
induced by gentamicin in ROP1/1 mice was mediated
by a direct effect on ureteric bud branching. This reduc-
tion occurred if gentamicin was started either before
or after the onset of nephrogenesis. Thus, the risk of
developing a reduction in glomerular number following
intrauterine exposure to renal toxins is not limited to
the initial phases of renal development and may continue
until ureteric bud branching is complete.
Fig. 5. Glomerular counts in C57BL/6 and ROP1/1 kidneys after in Gentamicin-treated ROP1/1 females gained signifi-
vitro exposure to gentamicin-containing (j) or control medium (h; cantly less weight than did their saline-injected controls
Protocol 2A). The number of glomeruli in C57BL/6 kidneys (N 5 8)
from E8 through E12. However, gentamicin-treatedwas identical in gentamicin-containing and control medium. However,
in ROP1/1 kidneys (N 5 11), there were 25% fewer glomeruli in C57BL/6 females gained only slightly less weight than
gentamicin-containing medium. Data are mean 6 sd, P , 0.01. their saline-treated controls during this period. This sug-
gests that, although maternal gentamicin toxicity is pres-
ent in both strains, it is more pronounced in ROP1/1
mice. The gestation time was normal in both gentamicin-Treatment after the onset of nephrogenesis
and saline-treated mice of both mouse strains in this
Effects on glomerular number in vitro. There was a study. These data differ from that in the Sprague Dawley
25% reduction in glomerular number in gentamicin- rat, in which gestation time was shortened by gentamicin
treated ROP1/1 kidneys compared with contralateral treatment [7].
kidneys grown in normal medium (Figs. 4 and 5; P , The birthweight of gentamicin-treated and saline-
0.01). The glomerular number in C57BL/6 kidneys was
treated ROP1/1 pups was identical. Therefore, the re-
unaffected by gentamicin treatment.
duction in glomerular number in gentamicin-treated
ROP1/1 mice was likely a direct gentamicin effect and
DISCUSSION could not be ascribed to a change in birthweight. The
pups of gentamicin-treated ROP1/1 mice, which wereThe effects of gentamicin on glomerular number and
subsequently cannibalized, had lower birth weights thanureteric bud branching were investigated in ROP1/1
saline-treated controls. Because low birthweight and de-mice, a glomerulosclerosis-prone strain, and C57BL/6
creased nephron number are linked, the nephron num-mice, a glomerulosclerosis-resistant strain [4]. Gentami-
ber in these mice might be expected to be reduced com-cin reduced the glomerular number and ureteric bud
pared with saline-treated controls [13]. Therefore, thebranches in only ROP1/1 mice. This effect was shown
to be a direct consequence of gentamicin exposure, by loss of data from these pups would be expected to bias
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hypoplasia with hypertrophy of nephrons (oligomeganephronia):the data toward an underestimation rather than an exag-
Studies by microdissection. Am J Clin Pathol 52:199–207, 1969
geration of a gentamicin-induced reduction of glomeruli. 3. Broyer M, Soto B, Gagnadoux MF, Adi M, Rica C, Gubler MC:
Hypoplasie oligomeganephronique, in Actualite´s Ne´phrologiques,We found that gentamicin treatment reduced the glo-
edited by Gru¨nfeld JP, Bach JF, Kreis H, Paris, Me´decine-Sci-merular number in ROP1/1 mice by 10 to 36%. This
ences Flammarion, 1996, pp 47–62
was considered to be a functionally significant change 4. He C, Esposito C, Phillips C, Zalups RK, Henderson DA,
Striker GE, Striker LJ: Dissociation of glomerular hypertrophy,because a 20% decrement in glomerular number was
cell proliferation, and glomerulosclerosis in mouse strains hetero-sufficient to accelerate the development of glomerular
zygous for a mutation (Os) which induces a 50% reduction in
lesions in adult Sprague-Dawley rats [15]. Because nephron number. J Clin Invest 97:1242–1249, 1996
5. Esposito C, He CJ, Striker GE, Zalups RK, Striker LJ: NatureROP1/1 mice are glomerulosclerosis prone, a compara-
and severity of the glomerular response to nephron reduction isble nephron reduction most likely constitutes an impor-
strain-dependent in mice. Am J Pathol 134:891–897, 1999
tant additional renal risk factor in this mouse strain. 6. Zheng F, Striker GE, Esposito C, Lupia E, Striker LJ: Strain
differences rather than hyperglycemia determine the severity ofNephrogenesis in vitamin A-deficient Sprague-Daw-
glomerulosclerosis in mice. Kidney Int 54:1999–2007, 1998ley rats is impaired, evidence that in utero metabolic
7. Gilbert T, Lelievre-Pegorier M, Malienou R, Meulemans A,
events may also influence nephron number [16]. The Merlet-Benichou C: Effects of prenatal and postnatal exposure
to gentamicin on renal differentiation in the rat. Toxicology 43:301–impact of an abnormal in utero metabolic environment
313, 1987has recently been studied in Pima Indians [17]. There
8. Gilbert T, Gaonach S, Moreau E, Merlet-Benichou C: Defect
was a positive association demonstrated between the of nephrogenesis induced by gentamicin in rat metanephric organ
culture. Lab Invest 70:656–666, 1994presence of type 2 diabetes in the mother during preg-
9. Avner ED, Ellis D, Temple T, Jaffe R: Metanephric developmentnancy and the development of an elevated urinary albu- in serum free organ culture. In Vitro 18:675–682, 1982
min excretion rate in adulthood. 10. Ekblom P, Thesleff I, Saxen L, Miettinen A, Timpl R: Transferrin
as a fetal growth factor: acquisition of responsiveness related toIn summary, these data show that a mouse strain sus-
embryonic induction. Proc Natl Acad Sci USA 80:2651–2655, 1983ceptible to glomerulosclerosis develops a decrease in 11. Gilbert T, Cibert C, Moreau E, Geraud G, Merlet-Benichou
glomerular number following intrauterine exposure to C: Early defect in branching morphogenesis of the ureteric bud
in induced nephron deficit. Kidney Int 50:783–795, 1996renal toxins. Because a reduction in glomerular number
12. Hoar RM, Monie IW: Comparative development of specific organ
is an additional stimulus to glomerulosclerosis, prenatal systems, in Developmental Toxicology, edited by Kimmel CA,
Buelke-Sam J, New York, Raven Press, 1981, pp 13–33exposure to renal toxins may compound the hazard of
13. Merlet-Benichou C, Gilbert T, Muffat-Joly M, Lelievre-Peg-developing renal failure in sclerosis-prone individuals.
orier M, Leroy B: Intrauterine growth retardation leads to a per-
manent nephron deficit in the rat. Pediatr Nephrol 8:175–180, 1994Reprint requests to Gary E. Striker, M.D., Division of Nephrology,
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